Panniculitis does not predict clinical response in patients with advanced melanoma under targeted therapy

被引:0
作者
Marie Piroth
Thomas Goronflot
Romain Samaran
Emilie Varey
Alexandra Poinas
Amir Khammari
Brigitte Dreno
机构
[1] Nantes Université,CHU Nantes Service de Dermatologie, Hôtel
[2] Nantes Université,Dieu, Nantes
[3] Hôpital du Mans,CHU Nantes, Pôle Hospitalo
[4] Nantes Université,Universitaire 11: Santé Publique, Clinique des données, INSERM, CIC 1413
[5] Nantes Université,Service de Dermatologie
来源
European Journal of Dermatology | 2023年 / 33卷
关键词
BRAF inhibitor; MEK inhibitor; melanoma; oncology; panniculitis; targeted therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:126 / 136
页数:10
相关论文
共 50 条
  • [41] Connective tissue panniculitis and vitiligo in a patient with stage IV melanoma achieving complete response to dabrafenib and trametinib combination therapy
    Gargiulo, Luigi
    Tronconi, Maria Chiara
    Grimaudo, Maria S.
    Pavia, Giulia
    Valenti, Mario
    Manara, Sofia
    Costanzo, Antonio
    Borroni, Riccardo G.
    MELANOMA RESEARCH, 2021, 31 (06) : 586 - 588
  • [42] Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes
    Henary, H.
    Hong, D. S.
    Falchook, G. S.
    Tsimberidou, A.
    George, G. C.
    Wen, S.
    Wheler, J.
    Fu, S.
    Naing, A.
    Piha-Paul, S.
    Janku, F.
    Kim, K. B.
    Hwu, P.
    Kurzrock, R.
    ANNALS OF ONCOLOGY, 2013, 24 (08) : 2158 - 2165
  • [43] Molecular targeted therapy for patients with melanoma: the promise of MAPK pathway inhibition and beyond
    Sullivan, Ryan J.
    Atkins, Michael B.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (10) : 1205 - 1216
  • [44] Machine learning algorithm to predict response to immunotherapy in real-life settings for patients with advanced melanoma
    Cécile Frenard
    Katleen Blanchet
    Philippe Lecerf
    Emilie Varey
    Amir Khammari
    Brigitte Dréno
    European Journal of Dermatology, 2023, 33 : 75 - 80
  • [45] Towards combinatorial targeted therapy in melanoma: From pre-clinical evidence to clinical application (Review)
    Grazia, Giulia
    Penna, Ilaria
    Perotti, Valentina
    Anichini, Andrea
    Tassi, Elena
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (03) : 929 - 949
  • [46] Machine learning algorithm to predict response to immunotherapy in real-life settings for patients with advanced melanoma
    Frenard, Cecile
    Blanchet, Katleen
    Lecerf, Philippe
    Varey, Emilie
    Khammari, Amir
    Dreno, Brigitte
    EUROPEAN JOURNAL OF DERMATOLOGY, 2023, 33 (02) : 75 - 80
  • [47] Histogram analysis of iodine maps from dual energy computed tomography for monitoring targeted therapy of melanoma patients
    Uhrig, Monika
    Simons, David
    Ganten, Maria-Katharina
    Hassel, Jessica C.
    Schlemmer, Heinz-Peter
    FUTURE ONCOLOGY, 2015, 11 (04) : 591 - 606
  • [48] Toxicity of combined targeted therapy and concurrent radiotherapy in metastatic melanoma patients: a single-center retrospective analysis
    Ziegler, Johanna S.
    Kroeze, Stephanie
    Hilbers, Marie-Luise
    Imhof, Laurence
    Guckenberger, Matthias
    Levesque, Mitchell P.
    Dummer, Reinhard
    Cheng, Phil
    Mangana, Joanna
    MELANOMA RESEARCH, 2020, 30 (06) : 552 - 561
  • [49] Immunotherapy or targeted therapy as first-line treatment of patients with advanced/metastatic melanoma with the BRAF mutation - a single-center analysis
    Cybulska-Stopa, Bozena
    Piejko, Karolina
    Pacholczak, Renata
    Domagala-Haduch, Malgorzata
    Drosik-Kwasniewska, Anna
    Satek-Zan, Agata
    Wiktor-Mucha, Patrycja
    Rolski, Janusz
    Zemetka, Tomasz
    ONCOLOGY IN CLINICAL PRACTICE, 2020, 16 (04): : 194 - 200
  • [50] Combined ipilimumab and nivolumab first-line and after BRAF-targeted therapy in advanced melanoma
    Mason, Robert
    Dearden, Helen C.
    Nguyen, Bella
    Soon, Jennifer A.
    Smith, Jessica Louise
    Randhawa, Manreet
    Mant, Andrew
    Warburton, Lydai
    Lo, Serigne
    Meniawy, Tarek
    Guminski, Alexander
    Parente, Phillip
    Ali, Sayed
    Haydon, Andrew
    Long, Georgina V.
    Carlino, Matteo S.
    Millward, Michael
    Atkinson, Victoria G.
    Menzies, Alexander M.
    PIGMENT CELL & MELANOMA RESEARCH, 2020, 33 (02) : 358 - 365